• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchApnimed
    Picture of Apnimed logo

    APMD — Apnimed Share News

    $18.530.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    • Market Cap
      $771.42m
    • Enterprise Value
      $1.01bn
    • Revenue
      $38.47m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • APMD Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    APMD Dividends
    • U.S. STOCKS ON THE MOVE-GoDaddy, Amazon, Chevron

      31/07/2026 18:45
    • NASDAQ RESUMED AT 11:54 AM

      31/07/2026 16:54
    • Sleep apnea pill developer Apnimed rises in debut after upsized $192 mln IPO

      31/07/2026 16:53
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:49 AM

      31/07/2026 16:49
    • NASDAQ RESUMED AT 11:45 AM

      31/07/2026 16:45
    • Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO

      31/07/2026 16:32
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

      31/07/2026 09:00
    • Brief: Apnimed Announces Pricing Of Upsized Initial Public Offering

      31/07/2026 03:10
    • Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO

      27/07/2026 13:13

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.